Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

摘要

The present invention relates to a rapidly dissolving pharmaceutical composition comprising about 0.01 mg to 0.05 mg ethinylestradiol and about 2 mg to 4 mg drospirenone, together with one or more pharmaceutically acceptable carriers or excipients.